FDC Peer Comparison

NSE: FDC | BSE: 531599

₹360.20

₹-2.20 (-0.61%)

As on 22-Sep-2026 11:34IST

Market cap

₹5,864 Cr

Revenue (TTM)

₹2,190 Cr

P/E Ratio

P/B Ratio

2.2

Div. Yield

1.4 %

Edit

	FDC	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Market cap (₹ Cr)	5,864	21,460	20,797	17,919	18,493
Revenue (₹ Cr)	2,190	2,287	1,682	3,230	2,570
Net Profit (₹ Cr)	292.56	678.07	273.51	666.92	735.15
Net Margin (%)	12.56	28.10	16.19	20.60	26.88
RoE (%)	12.56	19.73	11.15	18.75	19.16
Price to Earnings	20.05	32.25	69.95	27.83	25.16
Price-To-Book	2.24	5.84	7.74	4.44	4.20

Income Statement (₹ Cr)

	FDC	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Operating Revenue	2,190.22	2,287.33	1,682.47	3,229.67	2,569.77
Total Income	2,329.19	2,413.29	1,689.83	3,237.12	2,735.39
Total Expenditure	1,854.76	1,490.75	1,203.91	2,090.06	1,628.14
EBITDA	335.46	796.58	478.55	1,139.61	941.63
Depreciation	59.47	78.10	126.01	281.06	57.58
EBIT	275.99	718.48	352.55	858.55	884.05
Interest	4.65	0.88	52.11	190.64	7.69
Other Income	138.97	125.96	7.37	7.45	165.62
Exceptional Items	-20.79	0.00	12.16	-17.24	-49.16
Profit before Tax	389.52	843.56	319.96	658.12	992.82
Provision for Tax	96.96	165.49	46.45	-8.80	257.67
Profit after Tax	292.56	678.07	273.51	666.92	735.15

	FDC	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Shareholder's Funds	2,485.11	3,586.42	2,591.20	3,902.67	4,202.90
Minority Interest	0.00	-12.71	0.00	-21.81	0.00
Non-Current Liabilities	69.78	28.74	266.35	1,392.75	91.50
Current Liabilities	364.08	385.94	848.06	2,077.10	627.48
Total Liabilities	3,938.74	4,037.51	3,705.61	7,246.72	4,921.88

	FDC	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Non-Current Assets	1,628.07	1,291.22	2,525.44	5,617.77	770.28
Current Assets	1,132.52	2,585.66	1,109.77	1,539.85	3,803.22
Total Assets	3,938.74	4,037.51	3,705.61	7,246.72	4,921.88
Total Debt*	0.00	0.57	657.97	2,309.68	2.50
Net Current Assets	768.45	2,199.72	261.71	-537.25	3,175.74
Contingent Liabilities	204.54	17.53	160.01	51.57	370.49

	FDC	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Cash From Operating Activities	200.45	523.24	342.18	537.99	967.57
Cash Flow from Investing Activities	-109.93	-582.30	-325.92	-369.46	-561.67
Cash from Financing Activities	-93.33	-46.46	13.62	-313.53	-798.31
Net Cash Inflow / Outflow	-2.80	-105.52	29.88	-145.00	-392.41

	FDC	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
ROCE (%)	15.93	24.97	11.43	14.47	23.39
ROE (%)	12.56	19.73	11.15	18.75	19.16
ROA (%)	10.39	18.69	7.80	9.26	14.95
EBIT Margin (%)	12.60	31.41	20.95	26.58	34.40
Net Margin (%)	12.56	28.10	16.19	20.60	26.88
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	FDC	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Revenue Growth (%)	3.40	15.01	27.91	9.59	10.69
EBIT Growth (%)	8.85	18.45	58.32	16.84	24.14
Net Profit Growth (%)	8.72	19.61	149.56	62.68	-9.09
EPS Growth (%)	14.73	17.73	-3.57	67.41	14.40
Book Value Growth (%)	8.94	26.75	9.67	36.71	-0.34

	FDC	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Price / Earnings	19.12	31.50	74.73	27.20	23.95
Price / Book Value	2.26	5.71	7.80	4.45	4.19
Dividend Yield (%)	1.38	0.29	0.06	0.00	1.86
EV/EBITDA	16.04	25.04	45.05	17.72	16.32
Market Cap (₹ Cr)	5,229.56	11,439.22	6,819.66	17,980.08	21,592.90

	FDC	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debt to Equity	0.00	0.00	0.07	0.24	0.00
Short term debt to equity ratio	--	0.00	0.16	0.12	0.00
Current Ratio	3.11	6.70	1.31	0.74	6.06
Quick Ratio	2.13	5.59	0.88	0.53	5.31
Interest Coverage	84.79	959.59	7.14	4.45	130.11

	FDC	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debtors to sales (%)	6.93	36.10	30.84	21.07	7.07
Asset Turnover	0.78	0.63	0.48	0.45	0.52
Receivable days	21.28	121.68	113.81	63.88	26.06
Inventory Days	59.64	63.83	84.76	43.27	65.95
Payable days	105.74	108.28	101.94	151.85	81.01
Cash Conversion Cycle	-24.83	77.23	96.62	-44.70	11.00

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.